Nice job, Thanks for taking the time and effort for all that research.  I actually read through the whole thing.  Very intriguing indeed.

So it is possible to see Orphan drug status this year ?

I know the 2 big PRs everyone is awaiting this year is FDA approval for trials, and the 2nd PR announcing Phase 1 of clinical trials.

I believe there are also going to be a couple of wild card PRs that will catch people by surprise, like a JV or private funding source, and or course Orphan drug status.

When I read DD like yours, it angers and saddens me that there are still fools out there trying to destroy and bash a company that its primary goal is to help people with a certain terminal and fatal disease.  Of course BMSNs ultimate goal is to make a profit.  But they want to do it by trying to save peoples lives.  And when people bash a company trying to be humanitarian in its efforts,  Its probably the most sad and pathetic group of people I have ever seen.

Its one thing to bash a gold mining, tech, oil stock, apparel or whatever stock. It just takes a certain level of pathetic sliminess to bash a medical stock trying to do good.  When ever I read superior DD like the one you just did, it just solidifies my ire against bashers even more.

Thanks for taking the time to share with everyone here.